Indirect (unconjugated) bilirubin is total bilirubin minus direct bilirubin, computed automatically when your lab reports both.
Mildly raised indirect bilirubin with normal liver enzymes is most often Gilbert's syndrome, which is harmless; higher values can reflect faster red blood cell breakdown.
Optimal Bilirubin, Indirect: 0.4-0.75 mg/dL.
Typically re-tested every 12 weeks.
Indirect bilirubin is the fraction of bilirubin circulating bound to albumin that the liver has not yet conjugated, meaning it has not yet been chemically joined to glucuronic acid and made water soluble.
The pathway behind it is simple to follow. Red blood cells circulate for roughly 120 days, and when they are retired, the heme inside their hemoglobin is opened up by the enzyme heme oxygenase, producing biliverdin, iron and carbon monoxide. A second enzyme, biliverdin reductase, converts biliverdin into bilirubin. At this stage the molecule is fat soluble and cannot be excreted in urine, so it travels through the blood attached to albumin. Research describes this pathway as more than a disposal route, with bilirubin acting as an endogenous antioxidant and signalling molecule rather than inert waste 1.
The liver is the next step. Hepatocytes take bilirubin up from the blood and the enzyme UGT1A1 conjugates it, turning it into direct (conjugated) bilirubin, which is water soluble and can be secreted into bile, delivered to the intestine and eliminated.
One practical detail matters when you read your report. Most laboratories measure total bilirubin and direct bilirubin, then calculate the indirect fraction by subtraction. Because it is a derived number, it carries the measurement variation of both parent values, which is one reason small shifts between draws are rarely meaningful on their own.
It matters because splitting bilirubin into its direct and indirect parts separates two very different stories, one about red cell turnover and liver uptake, the other about bile flow and liver cell injury.
When total bilirubin is raised on its own, professional guidance on evaluating abnormal liver chemistries points to fractionating the result and reading it alongside ALT, AST and alkaline phosphatase before drawing any conclusion 2. A predominantly indirect pattern with normal enzymes suggests something quite different from a predominantly direct pattern, and that distinction shapes which follow up tests are reasonable.
There is also a longevity angle, and it runs in a direction that surprises people. Because bilirubin scavenges free radicals, observational research has repeatedly linked bilirubin levels in the upper part of the normal range with a lower burden of atherosclerotic disease, while lower levels are associated with higher cardiovascular risk 3. Studies of people with Gilbert's syndrome, a common inherited pattern of reduced conjugation that produces mildly raised unconjugated bilirubin, describe a similar signal alongside a generally benign clinical course 4.
Tracked over time, the indirect fraction is most useful as a stable personal baseline. Knowing your usual value makes a genuine change easier to recognise, and makes an isolated blip easier to put in context.
Typical laboratory reference ranges for indirect bilirubin sit in the low single digits of mg/dL, and FitScript narrows that window for optimization purposes.
| Measure | Range (mg/dL) |
|---|---|
| Typical lab reference range | 0.2 to 1.2 |
| FitScript optimal range | 0.4 to 0.75 |
Reference ranges vary by laboratory, age and sex, and by the assay and calculation method used, so always read your result against the range printed on your own report. FitScript's optimal range is an optimization target used to interpret trends, not a diagnostic cut-off, and sitting outside it does not establish that anything is wrong.
Two reporting notes help avoid confusion. Some laboratories report bilirubin in µmol/L rather than mg/dL, with roughly 17 µmol/L to each mg/dL, so a value that looks alarming may simply be in different units. And newborn bilirubin is interpreted against entirely separate, age in hours based thresholds that do not apply to adults 5.
A high indirect bilirubin usually means bilirubin is being produced faster than the liver conjugates it, or that conjugation capacity is reduced, and it is read in combination with liver enzymes and red cell markers rather than alone.
What people notice. Often nothing at all. Mild elevations are typically silent and found incidentally on a panel. When total bilirubin climbs higher, the first visible sign is usually a yellow tint to the whites of the eyes, sometimes followed by yellowing of the skin. Because unconjugated bilirubin is not water soluble, it does not pass into urine, so dark urine points elsewhere and is worth mentioning to a clinician. People with faster red cell breakdown sometimes report fatigue, breathlessness on exertion or pallor, which reflect the anemia rather than the bilirubin itself 8.
Common contributors. Gilbert's syndrome is the most frequent explanation for an isolated, mildly raised unconjugated bilirubin with normal liver enzymes, and reviews describe it as a common, lifelong and generally benign reduction in UGT1A1 activity that tends to surface during fasting, dehydration, intercurrent illness, sleep loss or hard exercise 4. Diagnostic criteria for it rest on the combination of unconjugated predominance, normal liver chemistries and the absence of hemolysis, which is why clinicians look at the whole picture rather than one number 6. Increased red cell breakdown from any cause raises the indirect fraction, as does the resorption of a large bruise or hematoma. Rare inherited conjugation disorders exist and present very differently, usually early in life. In newborns, physiological jaundice reflects immature conjugation combined with high red cell turnover, and is managed with light based care according to age specific thresholds 57.
What it may mean over time. An isolated, mildly raised unconjugated bilirubin with normal enzymes and normal red cell indices is commonly regarded by laboratories and clinicians as a benign variant, and research suggests it is not associated with progressive liver disease 4. Ongoing hemolysis is a different situation, with consequences such as anemia and pigment gallstones, which is why the cause matters more than the number. A result that is markedly outside the standard range, or that comes with visible jaundice, abdominal pain, pale stools, dark urine or fever, is worth discussing with a clinician promptly. Never set an abnormal result aside because an article describes a pattern as usually benign.
A low indirect bilirubin is not a recognised clinical abnormality, and laboratories do not flag low values the way they flag high ones.
What people notice. Nothing. There are no symptoms attributed to a low unconjugated bilirubin, and the value is not used to explain how someone feels.
Common contributors. Normal biological variation accounts for most low readings. Values also drift downward with anything that reduces bilirubin production or speeds its clearance, including a longer average red cell lifespan and medications that induce the liver enzymes handling conjugation. Analytical factors matter too, since bilirubin degrades on exposure to light, so a sample left uncovered can read lower than the blood actually was. And because the indirect figure is calculated, a direct bilirubin measured at the low end of assay sensitivity can distort the subtraction.
What it may mean over time. This is where the antioxidant literature becomes relevant. Population studies indicate that people in the lowest part of the bilirubin distribution carry a higher burden of atherosclerotic and metabolic risk than those in the upper normal range, a pattern attributed in part to bilirubin's free radical scavenging activity 310. That is an association observed across groups, not a prediction about any individual, and there is no established way to raise bilirubin as a health strategy. The sensible reading of a low value is to look at the markers that actually drive cardiometabolic risk rather than at the bilirubin number itself.
Indirect bilirubin is one of the more state dependent markers on a standard panel, which is why the conditions of the draw deserve attention.
For a cleaner comparison across draws, keep the conditions consistent. Same approximate time of day, usual hydration, no unusual fast, and no hard session the day before.
FitScript does not currently test indirect bilirubin in a panel, so there is no FitScript result for this marker to appear in your dashboard on its own.
If you already have an indirect bilirubin value from another laboratory, you can upload your labs so that Atlas, FitScript's AI health advisor, can read it alongside the markers that are tracked. That context is the point. An unconjugated predominance with normal liver enzymes and normal red cell indices reads very differently from the same number sitting next to abnormal enzymes, and Atlas is built to look across markers rather than at one line in isolation.
The wider membership runs on repeated measurement, with 150+ biomarkers tested per year, and Atlas turns those results into your FitScript, the personalized output written from your own biology and updated as new results arrive. Where a result raises a question that a therapy might address, a licensed provider evaluates whether any prescription option is appropriate after reviewing you as a whole. Nothing here is a dose, a schedule or a recommendation to start anything.
This article is educational and is not medical advice. Discuss your results, and any treatment decision, with a clinician or licensed provider who can see your full history.
Indirect bilirubin is almost uninterpretable in isolation, so pair it with the markers that explain its two main drivers.
Indirect bilirubin measures the pigment from retired red blood cells before the liver conjugates it, and it is calculated rather than measured directly. Typical laboratory reference ranges run from 0.2 to 1.2 mg/dL, with FitScript's optimal range of 0.4 to 0.75 mg/dL used as an optimization target. A low value is not a recognised abnormality, though lower bilirubin is associated in population research with higher cardiometabolic risk 10. Because the marker moves with fasting, illness, training and sample handling, trends across consistent draws tell you far more than any single result, and the interpretation belongs with a clinician who can see the rest of your panel.
In most laboratories it is calculated. The analyser measures total bilirubin and direct bilirubin, and the indirect fraction is the difference between them. Because it is derived from two measurements, it carries the variation of both, which is one reason small differences between draws are rarely meaningful on their own.
A typical laboratory reference range is 0.2 to 1.2 mg/dL, and FitScript's optimal range is 0.4 to 0.75 mg/dL. Ranges vary by laboratory, age, sex and assay, so compare your value with the range printed on your own report. FitScript's optimal range is an optimization target, not a diagnostic cut-off.
Not by itself. A raised unconjugated fraction alongside normal ALT, AST and alkaline phosphatase points away from liver cell injury, which is why guidance on abnormal liver chemistries recommends fractionating bilirubin and reading it with the enzymes. Only a clinician reviewing your full panel and history can interpret the pattern.
Yes, and this is well described. Prolonged fasting is a recognised trigger for a rise in unconjugated bilirubin, and the effect tends to be larger in people with reduced conjugation enzyme activity. If you fasted unusually long before the draw, mention it, because the value may not represent your usual level.
Gilbert's syndrome is a common, inherited reduction in the activity of UGT1A1, the enzyme that conjugates bilirubin.
Laboratories do not flag low values, and there are no symptoms attributed to them. There is no established way to raise bilirubin deliberately.
Several can. Some increase red cell breakdown, some compete with bilirubin for uptake into liver cells, some inhibit the conjugating enzyme and raise the unconjugated fraction without causing liver injury, and others induce conjugation and lower it. Share your full medication and supplement list with the clinician reviewing your results.
FitScript does not currently test indirect bilirubin in a panel. If you already have a result from another laboratory, you can upload your existing labs so Atlas, FitScript's AI health advisor, can read it alongside the markers that are tracked and factor it into your FitScript.
Total bilirubin and direct bilirubin show how the total splits, hemoglobin helps distinguish increased red cell breakdown from reduced conjugation, and ALT, AST and GGT describe liver cell injury and bile duct activity. Read as a group, these markers explain a pattern that no single value can.